Antimicrobial resistance (Q33544582)

27 July 2017

1 reference

title

Antimicrobial resistance. (English)

1 reference

27 July 2017

main subject

antimicrobial resistance

1 reference

Neely AN

1

1 reference

27 July 2017

Holder IA

series ordinal

2

1 reference

27 July 2017

publication date

1 February 1999

1 reference

27 July 2017

1 reference

27 July 2017

volume

25

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

17-24

1 reference

Fear of MRSA--potential for future disaster

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Vancomycin resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Outbreak of infection with penicillin-resistant Streptococcus pneumoniae in a hospital for the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Microbial colonization of large wounds.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Canadian Multicenter Susceptibility Study, with a focus on cephalosporins, from 15 Canadian medical centers. The Canadian Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Infection and antibiotic therapy in 4000 burned patients treated in Milan, Italy, between 1976 and 1988.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

The best of times, the worst of times. The global challenge of antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Relapsing infection due to Enterobacter species: lessons of heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Chromosomally encoded ampC-type beta-lactamase in a clinical isolate of Proteus mirabilis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

beta-Lactamases in laboratory and clinical resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Methicillin-resistant Staphylococcus aureus versus the burn patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Rapid emergence of resistance to cefepime during treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Quinolone resistance in clinical isolates of Serratia marcescens

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Disseminated Candidiasis Due to Amphotericin B-Resistant Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Amphotericin B-resistant yeast infection in severely immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Emergence of resistance to amphotericin B during therapy for Candida glabrata infection in an immunocompetent host

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Fluconazole-resistant Candida parapsilosis fungemia in a patient with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Failure of all antifungal therapy for infection due to Candida albicans: a new AIDS-related problem?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Investigation of a cluster of systemic Candida albicans infections in a neonatal intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Infection with Acinetobacter in a burns unit

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

An outbreak of infections with Acinetobacter calcoaceticus in burn patients: contamination of patients' mattresses

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum beta-lactamase, originating from a contaminated ultrasonography coupling gel.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Twenty-five year review of Pseudomonas aeruginosa bacteremia in a burn center

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Epidemiology of infections with Pseudomonas aeruginosa in burn patients: the role of hydrotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

The use of aztreonam as an alternate therapy for multi-resistant Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Multidrug resistance--a sign of the times

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

The challenge of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Epidemiological Features of and Risk Factors for Infection by Streptococcus pneumoniae Strains with Diminished Susceptibility to Penicillin: Findings of a French Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Icelandic researchers are showing the way to bring down rates of antibiotic-resistant bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Emerging antibiotic resistance in Indian communities

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Changing the focus of infectious diseases to pathogen-specific therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Crisis in infectious diseases: time for a new paradigm?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Containment of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Strategies for stemming the tide of antimicrobial resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Antibiotic armageddon

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Antibiotic resistance in Spain: what can be done? Task Force of the General Direction for Health Planning of the Spanish Ministry of Health

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Antibiotic resistance worldwide--a Spanish task force responds

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

1 reference

7 January 2021

DNA vaccines -- a modern gimmick or a boon to vaccinology?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Cytokines as antimicrobial therapy for the T cell-deficient patient: prospects for treatment of nonviral opportunistic infections

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Interleukin-11 improves survival and reduces bacterial translocation and bone marrow suppression in burned mice

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Combined host and specific anti-Pseudomonas-directed therapy for Pseudomonas aeruginosa infections in burned mice: experimental results and theoretic considerations.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

Effects of immunoglobulin G and low-dose amphotericin B on Candida albicans infections in burned mice

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2898%2900134-X

7 January 2021

10.1016/S0305-4179(98)00134-X

Identifiers

DOI

1 reference

27 July 2017

1 reference